US EditionRFK Jr. will require shift in how new vaccines are tested, HHS says
- The US Department of Health and Human Services will require all new vaccines, including Covid-19 ones, to undergo placebo-controlled trials before licensure.
- This requirement follows the existing annual update system for Covid-19 vaccines, which parallels the flu vaccine approach but raises questions after the FDA missed an April 1 deadline on Novavax approval.
- Novavax's protein-based vaccine and updated vaccines from Pfizer and Moderna face new trial demands, while Covid-19 remains dangerous especially for elderly people who had over 36,000 deaths last year.
- Experts warn that placebo-controlled trials could delay updated Covid shots, risking vulnerable populations, though updated vaccines provide better protection for four to six months by matching circulating strains.
- HHS sees this as a radical change aiming to improve vaccine safety monitoring, but some experts affirm that current systems have effectively identified rare side effects like myocarditis and blood clots.
Insights by Ground AI
Does this summary seem wrong?
86 Articles
86 Articles
All
Left
13
Center
25
Right
16
Watauga Democrat+18 Reposted by 18 other sources
RFK Jr. to Change Vaccine Testing Rules
Key Takeaways
·Calhoun, United States
Read Full Article
RFK Jr. Will Order All New Vaccines to Undergo Placebo-Controlled Testing, Washington Post Reports
by Brenda Baletti, Ph.D., Childrens Health Defense: An HHS spokesperson told The Defender that in “a radical departure from past practices,” the agency will set a new rule. “All new vaccines will undergo safety testing in placebo-controlled trials prior to licensure.” The news drew both praise and criticism from medical experts. All new vaccines will […]
Coverage Details
Total News Sources86
Leaning Left13Leaning Right16Center25Last UpdatedBias Distribution46% Center
Bias Distribution
- 46% of the sources are Center
46% Center
L 24%
C 46%
R 30%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
